Dr. Jeff Cadeddu

Jeffrey Cadeddu, M.D., is one of Texas’ leading urologists in the surgical treatment of prostate and kidney disorders. As Director of the UT Southwestern Clinical Center for Minimally Invasive Treatment of Urologic Cancer, he has performed more than 4,000 robotic/laparoscopic procedures on the prostate and kidney and introduced a number of firsts in the minimally invasive surgical treatment of kidney cancer and kidney disease.

His training and extensive experience with kidney cancers in particular allow him to offer patients the full gamut of options in managing the disease without losing the kidney. Those options include ablation, an outpatient procedure in which the tumor is destroyed with a heated probe, rather than removed surgically. Dr. Cadeddu was the first in Texas to perform the procedure. He also has the most experience in North Texas with laparoscopic and robotic partial or total nephrectomy to remove kidney cancers.

Dr. Cadeddu's experience treating prostate cancer with laparoscopic and robotic techniques spans 20 years, making him one of the most experienced surgeons with these techniques in the state of Texas. He is experienced with the full spectrum of robotic technologies, including the new single port robotic system.

Along with an active clinical practice focused on minimally invasive procedures, Dr. Cadeddu maintains a robust research program aimed at developing new technologies and techniques that will make kidney or prostate surgery even less invasive, while also maximizing kidney function better than what has traditionally been done.

Dr. Cadeddu joined the faculty of UT Southwestern Medical Center, where he is a Professor of Urology and Radiology, in 1999 after receiving his initial medical training and completing residencies in urology and surgery at Johns Hopkins School of Medicine in Baltimore.

As an expert in the treatment of kidney and prostate cancer, Dr. Cadeddu regularly lectures and educates other medical professionals on the latest developments in managing urologic conditions. In 2007, he received the Gold Cystoscope Award from the American Urological Association for his contributions to advances in kidney cancer treatment and the training of numerous academic urologists. In 2018, he received the Watson Award at UT Southwestern recognizing his outstanding clinical skills and compassionate patient care.

For over a decade, he has been included in D Magazine's Best Doctors list and has been named a Texas Monthly Super Doctor.